Angiogenesis and Inflammation in Biological Barriers 3.0
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (15 July 2023) | Viewed by 2560
Special Issue Editor
Interests: pregnancy pathologies; biological barriers; inflammasomes; angiogenesis; inflammation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Owing to the success of our first and second Special Issues on angiogenesis and inflammation in biological barriers, I am pleased to announce the launch of a third volume. This Special Issue will gather publications that focus on two key processes, angiogenesis and inflammation, which strongly contribute to the functioning of highly vascularized biological barriers (BBs). The scope of this third Issue will be more focused on BB-associated pathologies. Biological barriers are essential for the integrity and proper functioning of many vertebrate organs, and are critical for the regulation of tissue homeostasis and protection against pathogens or other tissue-damaging agents. BBs separate internal and external compartments, and are formed by specialized cell types, such as epithelial and endothelial cells, that interface the body and the external environment. Recent studies have uncovered the role of new inflammatory and angiogenic proteins in the control of the integrity of these BBs and their physiological functioning. Deregulations in the expression and/or function of these proteins may explain BB-associated pathologies such as infections, exacerbated inflammation, tissue injury, and cancer. This Special Issue welcomes original research articles and reviews focused on pathological angiogenesis and inflammation in highly vascularized biological barriers.
Dr. Nadia Alfaidy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biological barriers
- inflammasome
- angiogenesis
- inflammation
- vascularization
- angiogenic factors
- oxidative stress
- cancer
